XBiotech's Vilamakitug Clears FDA IND Review for Phase II Axial SpA Trial
The 30-day FDA review with no clinical hold signals a clear regulatory path forward for the IL-1α–targeting monoclonal …
The 30-day FDA review with no clinical hold signals a clear regulatory path forward for the IL-1α–targeting monoclonal …
The V-SPINE study opens U.S. enrollment for a condition with significant unmet need, signaling continued biotech intere…
Submission does not meet Functional News editorial scope. No ingredient, clinical endpoint, structure-function claim, o…
The stevia-free, still-format launch positions coconut water as a functional gut-health vehicle in a crowded better-for…
The deal extends smartwater's foodservice-adjacent distribution into boutique fitness, a growing channel for functional…
The Las Vegas-based brand moves beyond its growth-support supplement core into whole-food formats, signaling a broader …
The findings reinforce cortisol modulation as a credible clinical target — and raise formulation questions for the adap…
The characterization study aims to quantify how long the biopolymer barrier persists in the nasal cavity — a critical c…
GREY GOOSE debuts Berry Rouge with Zoe Saldaña, chef Dominique Ansel, and DJ Andre Power — a cohesive summer campaign b…
Square has grown far beyond mobile payments to become a critical infrastructure partner for Canada's restaurants and ca…
With bold sweet-tart flavor, all-day versatility, functional appeal, and an American-grown story, Montmorency tart cher…
Givaudan's European Taste & Wellbeing insights team adopted Stravito's AI-powered platform, dubbed "Genie," to run proj…